RBC Capital Maintains Outperform on Sophia Genetics, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara maintains an Outperform rating on Sophia Genetics (NASDAQ:SOPH) but lowers the price target from $8 to $7.
August 07, 2024 | 5:39 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RBC Capital analyst Conor McNamara maintains an Outperform rating on Sophia Genetics but lowers the price target from $8 to $7.
The Outperform rating suggests continued confidence in the company's performance, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100